Similar Stories to Human Genome Agrees To Glaxosmithkline Takeover on Bing News

Human Genome agrees to GlaxoSmithKline takeover Associated Press Copyright 2012 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Updated 03:19 p.m., Monday, July 16, 2012 N.J. (AP) — U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK's drug portfolio in crucial areas: biologic drugs and treatments for the hundreds of millions of people with diabetes and heart disease. Most other treatments either simply reduce inflammation and pain, take months to improve symptoms or can cause a host of significant side effects. Benlysta, a biologic drug produced in living cells, is meant to block or limit immune system attacks on the patient's cells and tissue, which cause inflammation and damage to organs. The deal also brings GSK two promising experimental drugs in late-stage human testing, albiglutide for Type 2 diabetes and darapladib, a heart drug being tested for prevention of stroke and heart attack. GSK's higher offer followed news of positive results on albiglutide from a study of cardiac safety — an issue that's now crucial for winning U.S.

More Business News

Oculus founder Palmer Luckey unveils his latest project: a retro Game Boy-like device
Fast Company, Wednesday - 06/05/2024 - 04:05 AM
The controversial founder’s candy-colored portable gaming devices are designed to play classic Nintendo Game Boy games as well as some new and unreleased titles. Nintendo’s Switch might be a portable gaming device for some, but for old school players, the Game Boy will always be the gold standard of handheld gaming.
More | Talk | Read It Later | Share
SpaceX is about to launch Starship again—the FAA will be more forgiving this time
Ars Technica, Tuesday - 06/04/2024 - 11:56 PM
Enlarge / The rocket for SpaceX's fourth full-scale Starship test flight awaits liftoff from Starbase, the company's private launch base in South Texas. (credit: SpaceX) The Federal Aviation Administration approved the commercial launch license for the fourth test flight of SpaceX's Starship rocket Tuesday, with liftoff from South Texas targeted for just after sunrise Thursday. "The FAA has approved a license authorization for SpaceX Starship Flight 4," the agency said in a statement.
More | Talk | Read It Later | Share
Charlottesville's Caju AI lands $3M seed round
BizJournals, Tuesday - 06/04/2024 - 08:57 PM
The company will use the funding to expand into new markets.
More | Talk | Read It Later | Share
Mass Fintech Hub names Thurlow, Merritt as new co-chairs
BizJournals, Tuesday - 06/04/2024 - 08:47 PM
Julie Thurlow, president and CEO of Reading Cooperative Bank, and Sears Merritt, head of enterprise technology and experience at MassMutual, were named co-chairs of the Mass Fintech Hub.
More | Talk | Read It Later | Share
VC funding update: Who raised money in May?
BizJournals, Tuesday - 06/04/2024 - 08:43 PM
In a month full of VC funding, here are the companies that raised the most money in May.
More | Talk | Read It Later | Share
Washington Post shakes up newsroom leadership, launches new business unit
BizJournals, Tuesday - 06/04/2024 - 08:40 PM
From the Washington Business Journal. In a bid to reverse steep declines in revenue and readers, the Washington Post is shaking up its newsroom leadership and launching a new division aimed at capturing new audiences. The Post announced late Sunday that Executive Editor Sally Buzbee has stepped down and that Matt Murray, the former editor in chief at the Wall Street Journal, has replaced her and will serve in the role until the 2024 presidential election.
More | Talk | Read It Later | Share

Similar Stories to Human Genome Agrees To Glaxosmithkline Takeover on Bing News

Welcome to Wopular

MoviesWithButter : Our Sister Site

More Business News